Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: One-year outcomes and investigative results

Ophthalmology

Volumn 120, Issue 7, 2013, Pages 1448-1453

  Goldberg, Roger A ^a,b   Flynn Jr , Harry W ^a   Miller, Darlene ^a   Gonzalez, Serafin ^a   Isom, Ryan F ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; DNA;

ARTICLE; CLINICAL ARTICLE; DNA DETERMINATION; ENDOPHTHALMITIS; ENUCLEATION; EVISCERATION; FOLLOW UP; GENE SEQUENCE; HOUSEKEEPING GENE; HUMAN; MEDICAL RECORD REVIEW; MICROBIOLOGICAL EXAMINATION; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; SYRINGE; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHAPERONIN 60; DISEASE OUTBREAKS; DNA, BACTERIAL; DRUG COMPOUNDING; DRUG CONTAMINATION; ENDOPHTHALMITIS; EYE INFECTIONS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 84879798373     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.12.009     Document Type: Article

References (30)

1. C.A. McCannel Meta-analysis of endophthalmitis following intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies Retina 31 2011 654 661
2. A.A. Moshfeghi, P.J. Rosenfeld, H.W. Flynn Jr Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center Retina 31 2011 662 668
3. CATT Research Group Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 2011 1897 1908
4. J.C. Wen, C.A. McCannel, A.B. Mochon, O.B. Garner Bacterial dispersal associated with speech in the setting of intravitreous injections Arch Ophthalmol 129 2011 1551 1554
5. A.M. Schimel, I.U. Scott, H.W. Flynn Jr Endophthalmitis after intravitreal injections: should the use of face masks be the standard of care? Arch Ophthalmol 129 2011 1607 1609
6. C.C. Wykoff, H.W. Flynn Jr, P.J. Rosenfeld Prophylaxis for endophthalmitis following intravitreal injection: antisepsis and antibiotics Am J Ophthalmol 152 2011 717 719
7. C.C. Wykoff, H.W. Flynn Jr Endophthalmitis after intravitreal injection: prevention and management Retina 31 2011 633 635
8. R.A. Goldberg, H.W. Flynn Jr, R.F. Isom An outbreak of Streptococcus endophthalmitis after intravitreal injection of bevacizumab Am J Ophthalmol 153 2012 204 208
9. M. Fielden, B. Nelson, A. Kherani Acute intraocular inflammation following intravitreal injection of bevacizumab - a large cluster of cases [letter online] Acta Ophthalmol 89 2011 e664 e665
10. T. Sato, K. Emi, T. Ikeda Severe intraocular inflammation after intravitreal injection of bevacizumab Ophthalmology 117 2010 512 516
11. X. Sun, X. Xu, X. Zhang Counterfeit bevacizumab and endophthalmitis [letter] N Engl J Med 365 2011 378 379 author reply 379
12. S.H. Lee, S.J. Woo, K.H. Park Serratia marcescens endophthalmitis associated with intravitreal injections of bevacizumab Eye (Lond) 24 2010 226 232
13. T. Wilemon Hospital gave tainted shots The Tennessean August 7, 2011 1B, 5B
14. A. Pollack Five more reports of Avastin injections causing Blindness The New York Times September 1, 2011 http://www.nytimes.com/2011/09/02/business/ more-reports-of-avastin-causing-blindness.html?-r=0 Accessed September 1, 2011
15. Centers for Disease Control and Prevention (CDC) Notes from the field: multistate outbreak of postprocedural fungal endophthalmitis associated with a single compounding pharmacy - United States, March-April 2012 MMWR Morb Mortal Wkly Rep 61 2012 310 311
16. Centers for Disease Control and Prevention Health Alert Network Update: multistate outbreak of fungal meningitis and joint infections associated with contaminated steroid medications October 17, 2012 http://emergency.cdc.gov/HAN/ han00329.asp Accessed October 17, 2012
17. Food and Drug Administration Form FDA 483: Inspectional Observations (for a compounding pharmacy in Florida) July and September 2011 http://www.fda.gov/ downloads/AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOperationsandPolicy/ ORA/ORAElectronicReadingRoom/UCM304256.pdf Accessed October 18, 2012
18. Public Health Service, Food and Drug Administration, Florida District Warning letter FLA-12-37 http://www.fda.gov/ICECI/EnforcementActions/ WarningLetters/2012/ucm317190.htm July 30, 2012 Accessed October 18, 2012
19. J.M. Miller, I.U. Scott, H.W. Flynn Jr Endophthalmitis caused by Streptococcus pneumoniae Am J Ophthalmol 138 2004 231 236
20. C.C. Chan, E.J. Holland, W.I. Sawyer Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes Cornea 30 2011 1105 1109
21. E. Alexandridis Silicone oil tamponade in the management of severe hemorrhagic detachment of the choroid and ciliary body after surgical trauma Ophthalmologica 200 1990 189 193
22. C. Skorpik, R. Menapace, H.D. Gnad, P. Paroussis Silicone oil implantation in penetrating injuries complicated by PVR Results from 1982 to 1986 Retina 9 1989 8 14
23. A. Ozdamar, C. Aras, R. Ozturk In vitro antimicrobial activity of silicone oil against endophthalmitis-causing agents Retina 19 1999 122 126
24. A. Shaarawy, M.G. Grand, T.A. Meredith, H.E. Ibanez Persistent endophthalmitis after intravitreal antimicrobial therapy Ophthalmology 102 1995 382 387
25. Pharmaceutical compounding - sterile preparations (USP Chapter 797) United States Pharmacopeia 27th rev. 2008 United States Pharmacopeial Convention Rockville, MD 1 61
26. R.M. Rich, P.J. Rosenfeld, C.A. Puliafito Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Retina 26 2006 495 511
27. S. Gonzalez, P.J. Rosenfeld, M.W. Stewart Avastin doesn't blind people, people blind people Am J Ophthalmol 153 2012 196 203
28. C. Stucki, A.M. Sautter, J. Favet, P. Bonnabry Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulation on end-product quality Am J Health Syst Pharm 66 2009 2032 2036
29. Centers for Medicare & Medicaid Services. Office of Clinical Standards and Quality/Survey & Certification Group Safe use of single dose/single use medications to prevent healthcare-associated infections. Memorandum to State Survey Agency Directors https://www.premierinc.com/quality- safety/tools-services/safety/topics/guidelines/downloads/CMS-Policy-Single-Dose- Vials-June-2012.pdf June 15, 2012 Accessed October 18, 2012
30. American Academy of Ophthalmology Clinical Statements. Verifying the source of compounded bevacizumab for intravitreal injections. February 2012 http://one.aao.org/ce/practiceguidelines/clinicalstatements.aspx Accessed May 24, 2012